Gujarat Kidney And Superspeciality Limited Announces Board Outcomes, Approves Q1 Results, Appoints New Independent Director
Gujarat Kidney And Superspeciality Limited, formerly known as Vihaan Medicare Private Limited, has announced several key outcomes from its recent board meeting. The company approved its Un-audited Financial Results and the Board's Report for the preceding financial year, while also making a significant governance move with the appointment of Mr. Paresh Dhoti as an Additional Non-Executive Independent Director.The results have been subjected to a limited review by the statutory auditor, M/s Y M Shah & Co., who issued an unmodified limited review report on the un-audited statements.
Financial Performance Highlights (Q1 Ended June 30, 2026)
The company provided both standalone and consolidated financial results for the first quarter ended June 30, 2026.Standalone Quarterly Un-audited Results:
The company reported a Total Income of Rs. 988.79 Lacs for the Quarter Ended June 30, 2026. The Profit after tax for the period stood at Rs. 203.71 Lacs.
A comparison across periods is as follows:
| Metric | Q ended June 30, 2026 (Un Audited) | Q ended March 31, 2026 (Un Audited) | Year Ended 2025 (Audited) | Year Ended 2026 (Audited) |
|---|---|---|---|---|
| Revenue From Operations (Rs. in Lacs) | 924.27 | 64.52 | 1,144.99 | 4,010.02 |
| Total Income (1) (Rs. in Lacs) | 988.79 | 969.38 | 1,145.14 | 4,059.47 |
| Profit/(loss) after tax for the period (III-IV) (Rs. in Lacs) | 203.71 | 136.78 | 990.14 |
Consolidated Quarterly Un-audited Results:
The consolidated results showed a strong Total Income of Rs. 3,497.82 Lacs for the quarter ended June 30, 2026. The Profit/(loss) after tax attributable to Owners of the company was recorded at Rs. 518.15 Lacs.
Key consolidated figures are summarized below:
| Metric | Q ended June 30, 2026 (Un Audited) | Year Ended 2026 (Audited) |
|---|---|---|
| Revenue From Operations (Rs. in Lacs) | 3,428.92 | 8,201.34 |
| Total Income (1) (Rs. in Lacs) | 3,497.82 | 8,288.60 |
| Profit/(loss) after tax attributable to Owners (Rs. in Lacs) | 518.15 | 1,549.69 |
Corporate Governance and Appointments
The board meeting also approved the Board's Report for the financial year ended March 31, 2026. The company’s 7th Annual General Meeting has been scheduled for Monday, September 28, 2026. M/s SPANJ & Associates, a Practicing Company Secretary firm, was appointed as the Scrutinizer for this meeting.Appointment of Additional Director
The Board appointed Mr. Paresh Dhoti (DIN: 11802188) as an Additional Non-Executive Independent Director effective August 14, 2026. Mr. Dhoti was previously appointed as a Non Executive Non Independent Director in the board meeting held on July 9, 2026.
Regarding his profile, Mr. Paresh Dhoti holds a Bachelor of Dentistry degree from Government Medical College, Ahmedabad (2006). He has been practicing independently as a Dentist in Vadodara for the last 18 years and is not related to any director of the company.
GKSL Stock Price Movement
On Friday, Gujarat Kidney And Super Speciality Limited shares edged higher in the market, closing at ₹136.43 after gaining 0.38%. The stock traded within a tight intraday band of ₹134.42 to ₹139 and saw 138,973 shares change hands during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: